SECsense Logo

Aspire Biopharma Holdings: Key Insights from Form 8-K Filing on February 17, 2025

$PWUP
Form 8-K
Filed on: 2025-02-21
Source
Aspire Biopharma Holdings: Key Insights from Form 8-K Filing on February 17, 2025

Based on the provided financial report excerpt, here are the key pieces of information and insights:

  1. Company Information:
  • Entity Name: Aspire Biopharma Holdings, Inc.
  • CIK: 0001847345
  • Address: 194 Candelaro Drive #233, Humacao, PR 00791
  • Contact Number: (415) 592-7399
  1. Filing Information:
  • Filing Type: Form 8-K
  • Filing Date: February 17, 2025
  • SEC File Number: 001-41293
  • IRS Employer Identification Number: 33-3467744
  1. Stock Information:
  • Common Stock Par Value: $0.0001 per share
  • Ticker Symbol for Common Stock: ASBP (listed on NASDAQ)
  • Warrants: Each warrant is exercisable for one share of common stock
  • Ticker Symbol for Warrants: ASBPW (listed on NASDAQ)
  1. Contextual Information:
  • The report includes multiple contexts related to the financial position as of February 17, 2025, including information about the company's former address and the specific classes of stock.
  • The document uses XBRL (eXtensible Business Reporting Language) conventions for data representation, which is standard in SEC filings for structured financial data.
  1. Other Observations:
  • The report indicates that the company has a structured stock issuance with common stock and warrants, which can provide insights into the company's capital structure and potential dilution to existing shareholders when warrants are exercised.
  • The company appears to be making a regulatory filing, which could imply recent developments that might affect stockholder value or corporate governance.

Overall, the financial report provides essential details about Aspire Biopharma Holdings, its securities, and relevant filing information that could be significant for investors and analysts monitoring its performance and regulatory compliance.